Florence Vicaire

Florence joined Univercells Technologies in July 2022 as Chief Commercial Officer. In this new created role, she is responsible for the commercialization and continued expansion of the company’s enabling portfolio of biomanufacturing technologies and services.

Florence brings 25+ years of extensive experience in developing and structuring businesses in life sciences and bioprocess sectors across Europe, Asia, and the US, most recently as Gene Therapy Global Business Leader at Cytiva. Previously, she played a key role in successfully commercializing the iCELLis® bioreactor portfolio at ATMI Life Sciences, as well as founding and serving as CEO for a point of care diagnostic biotech start-up.

Florence holds an engineer degree in Biotechnology from the UTC Compiègne and an MBA in Marketing and Business Management from the ESSEC business school.